Financing ·
Converts Series R Preferred Stock into Common Stock at a 5-for-1 ratio
JAGXJaguar Health, Inc.
Jaguar Health converted each outstanding share of its Series R Convertible Preferred Stock into five shares of common stock on November 2, 2026. This conversion followed the earlier distribution of one share of Series O Preferred Stock for every share of voting common stock held as of October 13, 2026. The transaction resulted in a total of 13,345,986 shares of common stock issued and outstanding immediately after completion. Jaguar Health develops pharmaceutical products.